Amphastar Pharmaceuticals CEO Jack Zhang's 2018 pay rises 2% to $5.9M
Amphastar Pharmaceuticals reports 2018 executive compensation
By ExecPay News
Published: April 18, 2019
Amphastar Pharmaceuticals reported fiscal year 2018 executive compensation information on April 18, 2019.
In 2018, three executives at Amphastar Pharmaceuticals received on average a compensation package of $3.8M, a 1% increase compared to previous year.
Average pay of disclosed executives at Amphastar Pharmaceuticals
Jack Yongfeng Zhang, Chief Executive Officer, received $5.9M in total, which increased by 2% compared to 2017. 33% of Zhang's compensation, or $1.9M, was in option awards. Zhang also received $888K in bonus, $1.1M in salary, $1.9M in stock awards, as well as $15K in other compensation.
Mary Ziping Luo, Chief Operating Officer, received a compensation package of $3M, which increased by 3% compared to previous year. 30% of the compensation package, or $908K, was in salary.
Jason B. Shandell, General Counsel, earned $2.6M in 2018, a 1% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 18, 2019.